Fig. 1From: Combined inhibition of C5 and CD14 efficiently attenuated the inflammatory response in a porcine model of meningococcal sepsis Upper panel: Complement activation was measured as plasma TCC by multiplex technology at different time points during the experiments (mean with 95% CI). The positive control group and the group treated with coversin and rMIL2 (coversin/rMIL2) contained 12 animals each. Two sham animals are shown for comparison. Lower panel: Complement activity of the classical pathway was measured at different time points by the Complement system Screen WIESLAB® assay (mean with 95% CI). Statistical significance is given for the difference between the positive control and the treatment groupBack to article page